At Nanogen, Inc., we develop diagnostic products that enable physicians to deliver improved patient care. Our products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care.
Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. Our business focus is to bring better results to diagnostics and healthcare.
ELITech's innovative MGB Alert® technology provides labs with a powerful tool to detect variation in their real-time PCR assays.
Real-time Control Sets
Our MGB approach to real-time PCR produces better tests that easily fit into your workflow.
Nanogen Real-time PCR Testing
-
The ELITech Group announces the sale of microarray assets to Gamida for Life
The ELITech Group announces the sale of microarray assets to Gamida for Life PARIS, FRANCE – January 26, 2010 – The ELITech Group, a privately he...ELITech announces its new product line: ELITech Molecular Diagnostics
The ELITech Group is pleased to introduce you to our new product line ELITech Molecular Diagnostics (formerly known as Nanogen product line), providing high-v... 
-
Nanogen improves patient care by providing physicians and clinicians with diagnostic tests that give them better information faster, helping them more quickly and accurately determine the proper course of treatment.
-
Learn how Nanogen's quality products are helping physicians and clinicians provide better patient care every day. Our tests give you better results that ultimately lead to a better testing experience.